Literature DB >> 11698617

Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain.

S G Andreeva1, P Dikkes, P M Epstein, P A Rosenberg.   

Abstract

cGMP has been implicated in the regulation of many essential functions in the brain, such as synaptic plasticity, phototransduction, olfaction, and behavioral state. Cyclic nucleotide phosphodiesterase (PDE) hydrolysis of cGMP is the major mechanism underlying the clearance of cGMP and is likely to be important in any process that depends on intracellular cGMP. PDE9A has the highest affinity for cGMP of any PDE, and here we studied the localization of this enzyme in the rat brain using in situ hybridization. PDE9A mRNA is widely distributed throughout the brain with varying regional expression. The pattern of PDE9A mRNA expression closely resembles that of soluble guanylyl cyclase (sGC) in the rat brain, suggesting a possible functional association or coupling of these two enzymes in the regulation of cGMP levels. Most of the brain areas expressing PDE9A mRNA also contain neuronal nitric oxide synthase (NOS), the enzymatic source of NO and the principal activator of sGC. PDE9A is the only cGMP-specific PDE with significant expression in the forebrain, and as such is likely to play an important role in NO-cGMP signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698617      PMCID: PMC6762294     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

Review 1.  Cyclic GMP cascade of vision.

Authors:  L Stryer
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

2.  Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases.

Authors:  S H Soderling; S J Bayuga; J A Beavo
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

3.  Sleep-related neuronal discharge in the basal forebrain of cats.

Authors:  R Szymusiak; D McGinty
Journal:  Brain Res       Date:  1986-04-02       Impact factor: 3.252

4.  Sleep suppression after basal forebrain lesions in the cat.

Authors:  D J McGinty; M B Sterman
Journal:  Science       Date:  1968-06-14       Impact factor: 47.728

5.  Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression.

Authors:  N A Hartell
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

6.  Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A.

Authors:  K Fujishige; J Kotera; K Omori
Journal:  Eur J Biochem       Date:  1999-12

7.  Codistribution of GABA- with acetylcholine-synthesizing neurons in the basal forebrain of the rat.

Authors:  I Gritti; L Mainville; B E Jones
Journal:  J Comp Neurol       Date:  1993-03-22       Impact factor: 3.215

8.  Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.

Authors:  S Katsuki; W Arnold; C Mittal; F Murad
Journal:  J Cyclic Nucleotide Res       Date:  1977-02

9.  Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain.

Authors:  J De Vente; D A Hopkins; M Markerink-Van Ittersum; P C Emson; H H Schmidt; H W Steinbusch
Journal:  Neuroscience       Date:  1998-11       Impact factor: 3.590

10.  A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain.

Authors:  D R Repaske; J G Corbin; M Conti; M F Goy
Journal:  Neuroscience       Date:  1993-10       Impact factor: 3.590

View more
  23 in total

Review 1.  Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.

Authors:  Isaac Levy; Anelia Horvath; Monalisa Azevedo; Rodrigo Bertollo de Alexandre; Constantine A Stratakis
Journal:  Curr Opin Pharmacol       Date:  2011-10-31       Impact factor: 5.547

Review 2.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  A novel role for cyclic guanosine 3',5'monophosphate signaling in synaptic plasticity: a selective suppressor of protein kinase A-dependent forms of long-term potentiation.

Authors:  M Makhinson; P Opazo; H J Carlisle; B Godsil; S G N Grant; T J O'Dell
Journal:  Neuroscience       Date:  2006-03-23       Impact factor: 3.590

4.  The Phosphodiesterase 9 Inhibitor PF-04449613 Promotes Dendritic Spine Formation and Performance Improvement after Motor Learning.

Authors:  Baoling Lai; Miao Li; Wanling Hu; Wei Li; Wen-Biao Gan
Journal:  Dev Neurobiol       Date:  2018-07-18       Impact factor: 3.964

5.  Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.

Authors:  J J Luykx; S C Bakker; E Lentjes; M Neeleman; E Strengman; L Mentink; J DeYoung; S de Jong; J H Sul; E Eskin; K van Eijk; J van Setten; J E Buizer-Voskamp; R M Cantor; A Lu; M van Amerongen; E P A van Dongen; P Keijzers; T Kappen; P Borgdorff; P Bruins; E M Derks; R S Kahn; R A Ophoff
Journal:  Mol Psychiatry       Date:  2013-01-15       Impact factor: 15.992

Review 6.  Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?

Authors:  Dominic Ngima Nthenge-Ngumbau; Kochupurackal P Mohanakumar
Journal:  Mol Neurobiol       Date:  2017-01-06       Impact factor: 5.590

Review 7.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

8.  A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling.

Authors:  Xian-Feng Huang; Wen-Tao Jiang; Li Liu; Fang-Chen Song; Xia Zhu; Gui-Lan Shi; Shu-Ming Ding; Heng-Ming Ke; Wei Wang; James M O'Donnell; Han-Ting Zhang; Hai-Bin Luo; Yi-Qian Wan; Guo-Qiang Song; Ying Xu
Journal:  CNS Neurosci Ther       Date:  2018-05-02       Impact factor: 5.243

9.  Probing neurochemical structure and function of retinal ON bipolar cells with a transgenic mouse.

Authors:  Anuradha Dhingra; Pyroja Sulaiman; Ying Xu; Marie E Fina; Rüdiger W Veh; Noga Vardi
Journal:  J Comp Neurol       Date:  2008-10-10       Impact factor: 3.215

Review 10.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.